Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 67 of 661 for:    SMS

Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Appointment Attendance in DM Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03055702
Recruitment Status : Unknown
Verified February 2017 by The University of Hong Kong.
Recruitment status was:  Recruiting
First Posted : February 16, 2017
Last Update Posted : February 16, 2017
Sponsor:
Collaborator:
Hospital Authority, Hong Kong
Information provided by (Responsible Party):
The University of Hong Kong

Brief Summary:
A randomized controlled trial of patients with type 2 diabetes mellitus with multiple appointments into short message service group and control group. The attendance rate of these two groups of patients will be compared.

Condition or disease Intervention/treatment Phase
Appointments and Schedules Diabetes Mellitus, Type 2 Other: Mobile phone text message reminder Not Applicable

Detailed Description:

The main objective of this study is to evaluate the appointment attendance rate using SMS reminder of nurses and allied health appointments for diabetic patients, when compared to conventional telephone reminder and no reminder. We also aim at determine the factors associated with appointment attendance. Finally, we will also survey patients' acceptance and satisfaction to the SMS service.

This is a single blind randomization study. It will be carried out in Ha Kwai Chung General Outpatient Clinic.

The primary outcome of this study is to evaluate the attendance rate of each individual doctor, nurses and allied health clinic appointments for diabetic patients, as well as their overall attendance rates:

  1. Diabetes Complication Screening Clinic (OPAS DMCS/RDNA)
  2. Diabetes Nurse Intervention Clinic (OPAS DMIC/RDNI)
  3. DM nurse group (OPAS RDNG)
  4. Dietitian Counselling (OPAS DC/DG)
  5. Physiotherapy (OPAS PTC/PTG)
  6. Diabetes Doctor Session (OPAS RDR)
  7. Retino photo Assessment (OPAS RDO)
  8. Blood taking appointment (OPAS LABT)

The secondary outcomes are:

  • Acceptance Rate of SMS Reminder Vs Telephone Reminder Vs no reminder
  • Factors associated with acceptance of SMS

    1. Personal Parameters: Age, sex, educational level, occupation, mobile phone models, Habit of using mobile phone service
    2. Disease Parameters: Number and types of comorbidity, disease control (by biochemical markers)
    3. Quality of Life (by SF-6D)
  • Reported adverse effects of the reminder system
  • Chang in biochemical markers (BMI, HbA1c, LDL-c level) 6-9 months later

Subjects who agreed to participate in this study will first receive a survey on the acceptance of SMS service. For those agree to receive SMS reminder, they will be randomized to:

  1. an SMS remind them to come for scheduled clinic appointment 24-72 hours before, or
  2. usual care with no reminder / telephone reminder.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 270 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Type 2 Diabetes Mellitus Appointment Attendance in a Primary Care Clinic
Actual Study Start Date : November 1, 2016
Estimated Primary Completion Date : June 30, 2017
Estimated Study Completion Date : March 30, 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: SMS group
receive a mobile phone text reminder for scheduled clinic appointment 24-72 hours before,
Other: Mobile phone text message reminder
an SMS remind subjects to come for scheduled clinic appointment 24-72 hours before

No Intervention: Usual care group
Usual care, either telephone reminder or no reminder



Primary Outcome Measures :
  1. Attendance Rate of the scheduled clinic appointment [ Time Frame: between booking time and appointment time, usually within 1 weeks to 16 weeks ]
    Attendance Rate



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • With diagnosis of type 2 diabetes
  • Have more than 1 clinic services appointment under RAMP-DM programme:

    (e.g. blood taking, diabetic nurse individual counselling, group education, diabetic complication screening, retinal photo assessment, dietician counselling, etc)

Exclusion Criteria:

  1. Cannot read or receive appointment schedule on mobile phone
  2. Do not speak Cantonese/English or read Chinese/English
  3. Mentally incapacitated
  4. Pregnant Women

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03055702


Contacts
Layout table for location contacts
Contact: Man Chi Dao, M.B.B.S. +85236515411 thomasmcdao@gmail.com

Locations
Layout table for location information
Hong Kong
Ha Kwai Chung General Outpatient Clinic Recruiting
Kwai Chung, Hong Kong, 000
Contact: Man Chi Dao    +85236515411    thomasmcdao@gmail.com   
Principal Investigator: Man Chi Dao, M.B.B.S.         
Sub-Investigator: Sau Nga Fu, M.B.B.S.         
Sponsors and Collaborators
The University of Hong Kong
Hospital Authority, Hong Kong
Investigators
Layout table for investigator information
Principal Investigator: Man Chi Dao, M.B.B.S. Resident

Layout table for additonal information
Responsible Party: The University of Hong Kong
ClinicalTrials.gov Identifier: NCT03055702     History of Changes
Other Study ID Numbers: KW/EX-16-104(100-10)
First Posted: February 16, 2017    Key Record Dates
Last Update Posted: February 16, 2017
Last Verified: February 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by The University of Hong Kong:
Short Message Service
appointment reminder
Attendance rate
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases